48 related articles for article (PubMed ID: 9543218)
21. [Varicose veins and chronic venous insufficiency--minor disorder or disease? A critical review of the literature].
Madar G; Widmer LK
Z Lymphol; 1990 Aug; 14(1):36-46. PubMed ID: 2238803
[TBL] [Abstract][Full Text] [Related]
22. From symptoms to leg edema: efficacy of Daflon 500 mg.
Nicolaides AN
Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755
[TBL] [Abstract][Full Text] [Related]
23. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
Ulloa JH
Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
[TBL] [Abstract][Full Text] [Related]
24. The relevance of the natural history of varicose veins and refunded care.
Pannier F; Rabe E
Phlebology; 2012 Mar; 27 Suppl 1():23-6. PubMed ID: 22312063
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of micronized purified flavonoid fraction: an overview.
Struckmann JR
J Vasc Res; 1999; 36 Suppl 1():37-41. PubMed ID: 10474049
[TBL] [Abstract][Full Text] [Related]
26. The venous wall and valvular function in chronic venous insufficiency.
Thulesius O
Int Angiol; 1996 Jun; 15(2):114-8. PubMed ID: 8803634
[TBL] [Abstract][Full Text] [Related]
27. The influence of environmental factors in chronic venous insufficiency.
Jawien A
Angiology; 2003; 54 Suppl 1():S19-31. PubMed ID: 12934754
[TBL] [Abstract][Full Text] [Related]
28. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency.
Ramelet AA
Angiology; 2001 Aug; 52 Suppl 1():S49-56. PubMed ID: 11510597
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic approach to chronic venous insufficiency - clinical benefits of red-vine-leaf-extract AS 195 (Antistax
Stücker M; Rabe E; Meyer K; Ottillinger B; Schütt T
Pharmazie; 2019 Apr; 74(4):193-200. PubMed ID: 30940301
[No Abstract] [Full Text] [Related]
30. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.
Frick RW
Angiology; 2000 Mar; 51(3):197-205. PubMed ID: 10744007
[TBL] [Abstract][Full Text] [Related]
31. [The effect of dihydroergotamine on the venous system in patients with essential varices of the lower limbs].
Alvarez Sánchez J; Tiedt N
Angiologia; 1988; 40(5):174-8. PubMed ID: 3052181
[No Abstract] [Full Text] [Related]
32. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg.
Bergan JJ; Schmid-Schönbein GW; Takase S
Angiology; 2001 Aug; 52 Suppl 1():S43-7. PubMed ID: 11510596
[TBL] [Abstract][Full Text] [Related]
33. [Possibilities of pharmacotherapy for chronic venous insufficiency with diosmin preparations from the position of the endothelial functional state].
Kalinin RE; Suchkov IA; Pshennikov AS; Mzhavanadze ND
Angiol Sosud Khir; 2015; 21(3):91-4, 96-7. PubMed ID: 26355927
[TBL] [Abstract][Full Text] [Related]
34. CVD: a condition of underestimated severity.
Lattimer CR
Int Angiol; 2014 Jun; 33(3):222-8. PubMed ID: 24732585
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema.
Allaert FA
Int Angiol; 2012 Aug; 31(4):310-5. PubMed ID: 22801396
[TBL] [Abstract][Full Text] [Related]
36. Classification of chronic venous insufficiency: a review.
Antignani PL
Angiology; 2001 Aug; 52 Suppl 1():S17-26. PubMed ID: 11510593
[TBL] [Abstract][Full Text] [Related]
37. New Perspectives on Micronised Purified Flavonoid Fraction in Chronic Venous Disease: From Microvalves to Clinical Effectiveness.
Bouskela E; Lugli M; Nicolaides A
Adv Ther; 2022 Oct; 39(10):4413-4422. PubMed ID: 35951224
[TBL] [Abstract][Full Text] [Related]
38. [An update on the treatment of venous insufficiency in pregnancy].
Rodríguez-Nora B; Álvarez-Silvares E
Semergen; 2018; 44(4):262-269. PubMed ID: 29249567
[TBL] [Abstract][Full Text] [Related]
39. Optimising Decision Making in Chronic Venous Disease Management with Micronised Purified Flavonoid Fraction.
Ulloa JH
Clin Drug Investig; 2023 Jun; 43(Suppl 1):15-19. PubMed ID: 37081278
[TBL] [Abstract][Full Text] [Related]
40. Water displacement leg volumetry in clinical studies--a discussion of error sources.
Rabe E; Stücker M; Ottillinger B
BMC Med Res Methodol; 2010 Jan; 10():5. PubMed ID: 20070899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
